AlphAIalphai — Financial news for AI agents
investing.comSEP 32 min read$AVGO

Macquarie upgrades Broadcom on Anthropic compute ramp

Macquarie upgraded Broadcom (AVGO) to outperform, citing reduced risk from Google insourcing and exposure to Anthropic's compute growth. Analyst Arthur Lai expects Anthropic to spend over $40B with Broadcom by fiscal 2028. Q3 revenue rose 33% to $29.6B, with net profit beating estimates. Macquarie raised its price target to $490, implying a 35% return.

Original reporting
investing.com
Published Sep 3, 2026, 12:38 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 1:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefTechnology
Primary signal
$AVGO
Bullish
high confidence
Mentioned
$AVGO
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$AVGOBullishMed
01

Why it matters

The upgrade highlights a shift from previous concerns about Google insourcing to a bullish view on AI compute demand.

02

Market read

Analyst upgrade may trigger buying interest in Broadcom and related AI hardware stocks.

03

What to watch

Potential competition from emerging AI chip makers and macro slowdown could limit demand.

Relevance 7/10Novelty 7/10Timing: today

Background

Broadcom reported Q3 results in line with expectations, with AI semiconductor revenue outpacing software.

Company-level read

Ticker impact

$AVGOBullishHigh confidence
Context

Macquarie upgraded Broadcom, raised price target to $490 and forecast $40B of Anthropic compute spend by FY2028.

Expected impact

Potential 10-15% upside over the next 3-6 months if guidance holds.

Evidence & confidence

Upgrade is based on new contract forecasts and a broader customer base, reducing previous risk concerns.

Market effects

Sector

Strengthens the AI semiconductor sector outlook, supporting peers with similar XPU offerings.

Regional

Positive for US tech equities, especially hardware manufacturers.

Global

Reinforces confidence in AI supply chain investments worldwide.

Counterpoint

What could challenge this read

If Anthropic's spend forecasts fall short, Broadcom may face overcapacity and margin pressure.

Key entities

  • Company
    Broadcom

    US-listed semiconductor and software firm (AVGO).

  • Company
    Anthropic

    AI developer projected to spend $40B on Broadcom hardware.

Read at source← All news

Related articles

SEP 3
$AVGOHighAI 8/10

Wall Street Breakfast Podcast: Broadcom Beat Meets High Hopes

Broadcom (AVGO) shares fell 2.1% premarket despite beating Q3 earnings expectations, as weaker-than-expected guidance overshadowed results. Revenue rose 86% YoY to $29.59B, but Q4 revenue guidance of $34.8B missed estimates. Chipotle (CMG) opened its first Asian restaurant in Seoul, South Korea, and plans further expansion. The DOJ is investigating major grocery retailers over beef pricing. Snowflake (SNOW) shares surged 24% after strong Q2 results and upbeat outlook.

seekingalpha.com2 min
SEP 3
$AVGOMed

Broadcom slips as soft Q4 guide overshadows strong growth outlook: Buy the dip?

Broadcom (AVGO) shares fell 3.51% premarket to $354.36 after Q4 revenue guidance of $34.8B missed consensus of $35.05B, despite Q3 revenue and EPS beating estimates. Long-term growth targets remain high, with AI revenue expected to reach $115B in 2027 and $230B in 2028. Analysts note risks including customer concentration and supply constraints. The stock trades at a forward P/E of 30.5x, with FinQL's fair value estimate at $415.73, suggesting 13.2% upside.

investing.com2 min
SEP 3
$SNOWMed

Stocks making the biggest moves premarket: Snowflake, Moderna, Broadcom & more

Snowflake shares surged 24% after Q2 results beat estimates, with revenue of $1.55B and EPS of $0.62. Broadcom fell 2.5% on lower Q4 revenue forecasts. Campbell's dropped 7% on weak fiscal 2027 guidance. Ultragenyx plunged 46% after a failed drug trial. Petco rose 9% on strong Q2 margins. Moderna declined 2% after a downgrade. Argan gained 7.5% on better-than-expected earnings. Five Below rose 4.5% on strong Q2 results. Victoria's Secret fell 18% on missed revenue estimates. Netskope rose 12% on

cnbc.com3 min
SEP 3
$AVGOMed

Broadcom's AI chip bet raises questions over who foots the bill

Broadcom (AVGO) reported Q3 earnings beating expectations but shares fell 0.8% due to a lower-than-expected Q4 revenue forecast of $34.8B. CEO Hock Tan aims to double AI revenue to $115B by 2027 and $230B by 2028. CFO Amie Thuener noted potential 'residual value guarantees' for AI labs, indicating chipmakers may underwrite some financial risk for customers.

proactiveinvestors.co.uk2 min
SEP 3
$AVGOMed

Why Broadcom CEO Hock Tan Called Anthropic and OpenAI 'Two Geniuses in the Middle of Mongolia'

Broadcom (AVGO) CEO Hock Tan compared AI companies Anthropic and OpenAI to 'geniuses in Mongolia' needing help. The company is financing their AI infrastructure via its XPV platform, with a $35B deal closed for Anthropic. Tan expects Anthropic to surpass Google as Broadcom's top AI chip customer by 2027. Broadcom reported Q3 revenue of $29.59B, beating estimates, but Q4 guidance was slightly below expectations.

aol.com3 min